Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PSD 007

Known as: PSD-007 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

photocarcinorin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Comparison of Two Generation Photosensitizers of PsD-007 and Hematoporphyrin Monomethyl Ether Photodynamic Therapy for Treatment of Port-Wine Stain: A Retrospective Study.
Objective: To compare the efficacy and safety of the two generation photosensitizers, PsD-007 and hematoporphyrin monomethyl… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?
2014
2014
Study on pharmacokinetics of PSD-007 in BN rats by fluorescence detection methods
Objective To investigate the pharmacokinetic characteristics of PSD-007 in BN rats.Methods Blood of the BN rats was collected… Expand
Is this relevant?
2013
2013
Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10-dimethyl-1,2-benzanthracene-treated hamsters
The present study aimed to evaluate the efficacy of krypton laser photodynamic therapy (PDT) with PsD-007 for the treatment of… Expand
  • figure 1
  • figure 2
  • table I
  • table II
Is this relevant?
2010
2010
Photodynamic therapy of port-wine stains
Objectives: The purpose of this study was to observe the improvements of port-wine stains (PWSs) under photodynamic therapy (PDT… Expand
Is this relevant?
2010
2010
Treatment of oral florid papillomatosis with systemic administration of photocarcinorin: an effective photodynamic therapy.
OBJECTIVES To evaluate the safety and effect of systemic administration of photosensitizer Photocarcinorin (PsD-007) in the… Expand
  • figure 1
  • figure 2
Is this relevant?
2007
2007
Photodynamic therapy combined with local chemotherapy for the treatment of advanced esophagocardiac carcinoma.
BACKGROUND Photodynamic therapy (PDT) is an effective palliative treatment for gastrointestinal tumors. The aim of this clinical… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?
2002
2002
[Spectral properties of new photosensitizers for photodynamic diagnosis and therapy].
The spectral properties of new photosensitizer ZnPcS2P2, PsD-007 and HMME, as well as traditional photosensitizer HpD have been… Expand
Is this relevant?
1993
1993
Studies on the new tumor-photolocalizing and photochemotherapeutic agent photocarcinorin (PsD-007)
Photocarcinorin (PsD-007), a new porphyrin preparation for tumor-photolocalization and photodynamic therapy, was prepared. It… Expand
Is this relevant?
1987
1987
A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice.
Nine dyes, all potential sensitizers for photodynamic cancer therapy (PDT), were injected in mice with C3H mammary carcinomas… Expand
Is this relevant?
1986
1986
[Acute toxicity of PSD-007 (a new hematoporphyrin photosensitizer) in mice and dogs].
PSD-007 is a new hematoporphyrin photosen sitizer prepared in our laboratory. The 95% fiducial limits of its iv LD50 on mice were… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE